Chicago Atlantic group buys $25,158 in Vireo Growth stock

Chicago Atlantic Group, LP, a significant stakeholder in Vireo Growth Inc. (NASDAQ:VREO), recently acquired additional shares in the company amid a challenging period for the stock, which has declined over 24% in the past week. According to a recent filing, the group purchased 60,000 subordinate voting shares at a weighted average price of $0.4193 per share, amounting to a total investment of $25,158. The transaction was executed on April 4, 2025. According to InvestingPro analysis, Vireo Growth currently appears undervalued based on its Fair Value estimate.

Following this acquisition, Chicago Atlantic Group's direct ownership in Vireo Growth stands at 11,206,278 shares. This purchase reflects the group's continued investment in the pharmaceutical preparations sector, where Vireo Growth operates with a moderate debt-to-equity ratio of 1.62 and maintains a current ratio of 1.7. The transaction details highlight a price range of $0.4018 to $0.44 per share for the acquired stock, as noted in the filing. Get deeper insights into Vireo Growth's financial health and access 6 additional InvestingPro Tips, including detailed cash flow analysis and profitability forecasts.

In other recent news, Vireo Growth Inc. reported a 15.4% increase in full-year revenue, reaching $99.4 million, with fourth-quarter revenue rising 3.5% to $25 million. Despite this growth, the company faced a fourth-quarter net loss of $15.7 million due to one-time transaction expenses, which has raised concerns among investors. Vireo Growth is planning strategic initiatives, including the completion of a new cultivation facility in Minnesota and the expansion into adult-use sales, which are expected to drive a transformational year in 2025. The company maintains a strong cash position with $91.6 million at year-end, following an $81 million private placement completed in December. Analysts from Craig Hallum Capital Group have shown interest in the company's plans for its Minnesota and New York facilities, which are key to its growth strategy. Vireo Growth is also in the process of mergers, with expectations to close these transactions in 2025, pending regulatory and shareholder approvals. The company aims to build a portfolio of prolific cannabis brands, focusing on high returns for shareholders through strategic capital deployment. These recent developments reflect Vireo Growth's efforts to position itself for significant growth in the coming year.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.